Sumitomo Chemical India Ltd. · NSE:SUMICHEM

Sumitomo Chemical India — Q3 FY2020 Earnings Presentation

35 slides from Sumitomo Chemical India's earnings presentation, February 2020

  1. Slide 1: Sumitomo Chemical India Limited Investor Presentation

    Sumitomo Chemical India Limited Investor Presentation February 2020

  2. Slide 2: Safe Harbour

    Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Sumitomo Chemical India Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for

  3. Slide 3: Q3 & 9M Results Presentation

    Q3 & 9M Results Presentation

  4. Slide 4: Performance Highlights – Q3 & 9M FY20

    Performance Highlights – Q3 & 9M FY20 Revenue (Rs Crs) EBITDA (Rs. Crs) & EBITDA Margin (%) Adj PBT * (Rs Crs) ✓ Q3 FY20 revenue growth of +21% 21% YoY driven by broad- 50 +150% 46 20 523 36 based volume growth across 432 40 +183% products, geographies and 15 30 business segments 8.7% 10 20 18 ✓ Goo

  5. Slide 5: Consolidated Profit & Loss Account Statement

    Consolidated Profit & Loss Account Statement Particulars (Rs. Crs) Q3 FY20 Q3 FY19 YoY 9M FY20 9M FY19 YoY Revenue from Operations 523.0 432.2 21.0% 1,979.0 1,806.7 9.5% COGS 356.3 296.4 1,317.8 1,173.5 Gross Profit 166.7 135.7 22.8% 661.2 633.2 4.4% Gross Profit % 31.9% 31.4% 33.4% 35.0% Employee E

  6. Slide 6: Revenue Breakup – 9M FY20 Vs 9M FY19

    Revenue Breakup – 9M FY20 Vs 9M FY19 Product Breakup Geographic Breakup 5% 6% 9% 11% 8% 7% 49% 48% 83% 84% 9MFY19 9MFY20 12% 11% 17% 16% 18% 18% 9MFY19 9MFY20 Insecticides PGR Fungicides Domestic Export Herbicides Metal Phosphides AND & EHD* Segment Breakup Bulk & Branded Domestic Exports 15% 15% 73

  7. Slide 7: Key Developments

    Key Developments Listing ✓ Equity shares of SCIL were listed and admitted to dealings on the BSE (542920) and NSE (SUMICHEM) effective from January 27, 2020 ✓ The outstanding shares post listing stands at 49,91,45,736 of FV of Rs 10 ✓ The listing follows the successful completion of the merger of Ex

  8. Slide 8: Company Overview

    Company Overview Formidable Player in the Journey to 10x Growth Merger of Excel Crop Care Indian Agrochemicals Space in India Unlocking Value Autonomous Board with Vast To Benefit from Strong Industry Experience Parentage of SCC Japan

  9. Slide 9: Leading Agrochemicals Player in India

    Leading Agrochemicals Player in India Overview Diversified Product Portfolio & Segment Mix (FY19) 6% Incorporated in 2000 as a wholly owned subsidiary of SCC, Japan to drive ASD expansion of its Health & Crop Sciences business in India AND & EHD Primarily engaged in manufacture and sale of specialit

  10. Slide 10: Formidable Player in the Indian Agrochemicals Space

    Formidable Player in the Indian Agrochemicals Space Grown 10X* over FY11-19 Rs. Bn 5 190+ 10X Manufacturing Brands 22 Facilities 10+ 25+ / 200+ Technical Actives Patents / Registrations 2 13,000+ 1,500+ FY11 FY19 Distributors Employees *On an organic basis, grown 6X 10

  11. Slide 11: Journey to 10x Growth in India

    Journey to 10x Growth in India Exploration Phase: 2000 – 2009 Manufacturing JV with New Acquired product - 2000 Chemi 2002 Started EHD (Public Health) 2005 ‘Sulfosulfuron’ Leader 2010 business rights from Monsanto Started Animal Nutrition SCIL incorporated in India as 2001 Started ASD business 2003

  12. Slide 12: Merger of Excel Crop Care to Unlock Value

    Merger of Excel Crop Care to Unlock Value Pre-Merger Structure Post-Merger Structure SCC and its affiliates Public Shareholders (Japan) 44.98% SCC and its affiliates Public & Others (Japan) 35.03% Excel Crop Care (ECC) 100.00% 19.98% 80.3% 19.7% Sumitomo Chemical India Limited • SCIL issued shares t

  13. Slide 13: Well-diversified Platform of Scale (1/2)

    Well-diversified Platform of Scale (1/2) Parameter ECCL SCIL (Pre-Merger) SCIL (Post-Merger) Manufacturing Facilities Plants in Gujarat (2) and Plant in Maharashtra (1) and Dadar & Nagar Haveli (1) Gujarat (1) 5 plants in West India Predominantly a formulation Manufacturing Capability Presence in bo

  14. Slide 14: Well-diversified Platform of Scale (2/2)

    Well-diversified Platform of Scale (2/2) Parameter ECCL SCIL (Pre-Merger) SCIL (Post-Merger) Product Capability Major focus on Generics; nascent Major focus on Speciality Presence across complete presence in Biopesticides Products range of products Business Segments Presence only in agrochemical Pre

  15. Slide 15: Autonomous Board with Vast Industry Experience

    Autonomous Board with Vast Industry Experience Dr. Mukul Govindji Asher Chetan Shantilal Shah Chairman and Independent Director Managing Director ▪ Professorial Fellow at Lee Kuan Yew School of Public Policy at ▪ Commerce graduate from the University of Mumbai and the National University of Singapor

  16. Slide 16: Autonomous Board with Vast Industry Experience

    Autonomous Board with Vast Industry Experience Bhupendranath Bhargava Preeti Gautam Mehta Independent Non-executive Director Independent Non-executive Director ▪ Experience of over 50 years in areas including banking, ▪ 30 years of experience in corporate laws, foreign investment project financing a

  17. Slide 17: To Benefit from Strong Parentage of SCC Japan

    To Benefit from Strong Parentage of SCC Japan About SCC, Japan ✓ SCC is a leading Japanese research driven diversified chemical company listed on the Tokyo Stock Exchange with consolidated sales revenue for FY19 of US$ 20.8 bn and Health & Crop Sciences Sector of US$ 3.4 bn ✓ Offers diverse range of

  18. Slide 18: Sustainable Drivers for Growth

    Sustainable Drivers for Growth Diversified & De-risked Strategically Located Strong Focus on R&D and Portfolio Across the Agro- Manufacturing Facilities Process Innovation Chem Value Chain Strong Brand and Well- Expanding Brand Visibility Well placed to benefit from Entrenched Distribution and Conne

  19. Slide 19: Diversified & De-risked Portfolio Across the Agro-Chem Value Chain

    Diversified & De-risked Portfolio Across the Agro-Chem Value Chain Balanced Presence Across Key Sub-Segments Geographic Diversification with Exports to over 60 countries of the Agro-Chem Value Chain Insecticides 6% 4% North America 8% 8% Herbicides South America Domestic 16% PGR 8% 78% Europe Metal

  20. Slide 20: Strategically Located Manufacturing Facilities

    Strategically Located Manufacturing Facilities Connectivity to Major Cities and Proximity to Main Highways, Ports Reduces Logistic Time and Costs Plant Location Area (acres) Segment Served Product Manufactured Manufacturing of Technical Grade Pesticides Bhavnagar ~76 and Formulation Development Prod

  21. Slide 21: Strong Focus on R&D and Process Innovation

    Strong Focus on R&D and Process Innovation End-to-End Product Development Capabilities ✓ 3 fully equipped, DSIR approved R&D labs located at Mumbai, Bhavnagar and Gajod capable of synthesis, technical product and formulation development ✓ R&D Team comprises of 75+ qualified and dedicated engineers &

  22. Slide 22: Strong Brand and Well-Entrenched Distribution Network

    Strong Brand and Well-Entrenched Distribution Network ✓ Strong brand with market leading position across various product categories 23 States 68 Depots ✓ Dual brand portfolio can offer products at all price points serving multiple customer sub-segments 13,000+ ~40,000 ✓ In-depth knowledge of own res

  23. Slide 23: Expanding Brand Visibility and Connect

    Expanding Brand Visibility and Connect ✓ Wide range of generics and speciality products for Increased crop presence and providing crop protection solutions ✓ More than 1,400+ Relationship managers connecting to 1 million+ farmers throughout crop cycle ✓ Over 100 brands covering maximum of crops and

  24. Slide 24: Digital Marketing Initiatives

    Digital Marketing Initiatives Develop “Digital Marketing” as a parallel support to Traditional marketing system leading to improved sales. ✓ Our Digital Assets : 17 websites, currently driving about 6,342 visitors everyday. YouTube - Advantage http://www.danitolindia.com/ http://www.naturedeep.in/ I

  25. Slide 25: Well Placed to Benefit from Sector Tailwinds

    Well Placed to Benefit from Sector Tailwinds Pesticides: Market Share by Segment Highly Underpenetrated Market Significant growth opportunity for Indian Players 5% Pesticide Consumption (Kg/ha) Agrochemical Market Size (US$ bn) 1% 22% 13 12 +8% 8.1 FY18 47% 7 4.1 5 5 25% <1 Insecticides PGR Fungicid

  26. Slide 26: Thrust on Safety, Health and Environment (SHE)

    Thrust on Safety, Health and Environment (SHE) Quality Certifications Ensure Consistent product quality and healthy working environment at manufacturing sites Abiding by SCC Japan’s EHS Policies ISO:9001:2015, ISO-14001:2015 and OHSAS18001:2007 for the manufacturing sites at Bhavnagar, Gajod, Tarapu

  27. Slide 27: Growth Strategies & Financial Performance

    Growth Strategies Performance Highlights Growth Strategies & Financial Performance Profit & Loss Account Balance Sheet Cash Flow

  28. Slide 28: Growth Strategies

    Growth Strategies Continued Investment in R&D and Pipeline Capacity Expansion Achieving Market Leadership in • Aim to invest in seamless integration of R&D between SCIL and SCC • Driving operational efficiencies maintaining highest safety units which would help improve our production processes, stan

  29. Slide 29: Performance Highlights

    Performance Highlights Revenue (Rs Crs) EBITDA (Rs. Crs) & EBITDA Margin (%) PAT (Rs Crs) 11.3% 11.9% +16% 300 264 12 +14% 2,212 166 1,913 250 217 10 145 200 8 150 6 100 4 50 2 ✓ Combined entity ~2x in size 0 0 FY18* FY19 FY18 FY19 FY18 FY19 ✓ Net debt free balance sheet ✓ Strong margin profile main

  30. Slide 30: Consolidated Profit & Loss Account Statement

    Consolidated Profit & Loss Account Statement Particulars (Rs. Crs) FY19 FY18 YoY Net Revenue from Operations 2,211.7 1,912.9** 15.6% COGS 1,458.9 1,238.7 Gross Profit 752.8 674.2 11.7% Gross Profit % 34.0% 35.2% Employee Expenses 161.5 147.5 Other Operating Expenses 327.7 309.6 Operating EBITDA 263.

  31. Slide 31: Consolidated Balance Sheet

    Consolidated Balance Sheet Assets (Rs. Crs) Sep-19 Mar-19 Mar-18 Equity & Liabilities (Rs. Crs) Sep-19 Mar-19 Mar-18 Non-Current Assets 359.1 318.6 312.7 EQUITY 1,214.8 1,048.4 954.0 Property, Plant and Equipment 283.7 277.2 264.8 Equity Share Capital 274.6 274.6 274.6 Capital work-in-progress 4.5 3

  32. Slide 32: Consolidated Cash Flow Statement

    Consolidated Cash Flow Statement Cash Flow Statement (Rs. Cr) Sep-19 Mar-19 Mar-18 Net Profit Before Tax 224.2 259.8 221.0 Adjustments for: Non-Cash Items / Other Investment or Financial Items 21.0 18.6 9.6 Operating profit before working capital changes 245.2 278.5 230.6 Changes in working capital

  33. Slide 33: Awards & Accolades

    Awards & Accolades Jamnalal Bajaj Award for “Fair Business and Practices” Shramveer award for improvement of product efficiency received from national level Delhi First ever president’s gold shield for import substitution Vishwakarma Rashtriya Puraskar received for process development First award fo

  34. Slide 34: Key Takeaways

    Key Takeaways Formidable Player in the Indian Experienced Management Team Well-diversified Product Portfolio Strong Brand and Well-Entrenched Agro-chem Space and Board of Directors Across Agro-Chem Value Chain Distribution Network ▪ Strong / leadership position across ▪ Strong management and ▪ Multi

  35. Slide 35: For further information, please contact

    For further information, please contact: Company : Investor Relations Advisors : Sumitomo Chemical India Limited Strategic Growth Advisors Pvt. Ltd. CIN : U24110MH2000PLC124224 CIN : U74140MH2010PTC204285 Mr. Sushil Marfatia Mr. Varun Divadkar / Mr. Jigar Kavaiya Executive Director 97637 02204 / 992

Sumitomo Chemical India — Q3 FY2020 Earnings Presentation on 6ix